Publications for James Q. Del Rosso jqdelrosso@yahoo.com

Del Rosso, J. Q., Harper, J. C., Graber, E. M., Thiboutot, D., Silverberg, N. B., & Eichenfield, L. F. (2015). Status report from the American Acne & Rosacea Society on medical management of acne in adult women, part 2: Topical therapies. Cutis, 96(5), 321-325. This material can be found here.

Del Rosso, J. Q., Harper, J. C., Graber, E. M., Thiboutot, D., Silverberg, N. B., & Eichenfield, L. F. (2015). Status report from the American Acne & Rosacea Society on medical management of acne in adult women, part 3: Oral therapies. Cutis, 96(6), 376-382. This material can be found here.

Del Rosso, J. Q., Harper, J. C., Graber, E. M., Thiboutot, D., 
Silverberg, N. B., Eichenfield, D. Z., & Eichenfield, L. F. (2015). Status report from the American Acne & Rosacea Society on medical management of acne in adult women, part 1: Overview, clinical characteristics, and laboratory evaluation. Cutis, 96(4), 236-241. This material can be found here.

Del Rosso, J. Q. (2014). Calcipotriene–betamethasone dipropionate topical suspension in the management of psoriasis: A status report on available data with an overview of practical clinical application. American Journal of Orthopedics, 94(3), 127-134. This material can be found here.

Del Rosso, J. Q. (2014). Incorporation of a barrier protection cream in the management of chronic hand dermatitis: Focus on data supporting an established hand protectant formulation and modifications designed to assist in barrier repair. Journal of Clinical and Aesthetic Dermatology, 7(2), 40-48. PMCID: PMC3935650

Del Rosso, J. Q. (2014). Management of cutaneous rosacea: Emphasis on new medical therapies. Expert Opinion on Pharmacotherapy, 15(14), 2029-2038. doi:10.1517/14656566.2014.945423

Del Rosso, J. Q. (2014). The role of topical antifungal therapy for onychomycosis and the emergence of newer agents. Journal of Clinical and Aesthetic Dermatology, 7(7), 10-18. PMCID: PMC4106353

Del Rosso, J. Q. (2014). Topical therapy for acne in women: Is there a role for clindamycin phosphate-benzoyl peroxide gel? American Journal of Orthopedics, 4(94), 177-182. This material can be found here.

Del Rosso, J. Q., & Kircik, L. H. (2014). Update on the management of rosacea: A status report on the current role and new horizons with topical azelaic acid [Supplemental material]. Journal of Drugs in Dermatology, 13(12), s101-s107. This material can be found here.

Del Rosso, J. Q., & Plattner, J. J. (2014). From the test tube to the treatment room: Fundamentals of boron-containing compounds and their relevance to dermatology. Journal of Clinical and Aesthetic Dermatology, 7(2), 13-21. PMCID: PMC3935647

Del Rosso, J. Q., & Zeichner, J. (2014). What's new in the medicine cabinet? A panoramic view of clinically relevant information for the busy dermatologist. Journal of Clinical and Aesthetic Dermatology, 7(1), 26-30. PMCID: PMC3930537

Del Rosso, J. Q., Thiboutot, D., Gallo, R., Webster, G., Tanghetti, E., Eichenfield, L. F., . . . Zaenglein, A. (2014). Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 3: A status report on systemic therapies. Cutis, 93(1), 18-28.

Del Rosso, J. Q., Thiboutot, D., Gallo, R., Webster, G., Tanghetti, E., Eichenfield, L. F., . . . Zaenglein, A. (2014). Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 5: A guide on the management of rosacea. Cutis, 93(3), 134-138.

Leyden, J. J., Del Rosso, J. Q., & Baum, E. W. (2014). The use of isotretinoin in the treatment of acne vulgaris: Clinical considerations and future directions [Supplemental material]. The Journal of Clinical and Aesthetic Dermatology, 7(2), S3-S21. PMCID: PMC3970835

Tanghetti, E., Del Rosso, J. Q., Thiboutot, D., Gallo, R., Webster, G., Eichenfield, L. F., . . . Zaenglein, A. (2014). Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 4: A status report on physical modalities and devices. Cutis, 93(2), 71-76.

Two, A. M., & Del Rosso, J. Q. (2014). Kallikrein 5-mediated inflammation in rosacea: Clinically relevant correlations with acute and chronic manifestations in rosacea and how individual treatments may provide therapeutic benefit. Journal of Clinical and Aesthetic Dermatology, 7(1), 20-25. PMCID: PMC3930536

Coda, A. B., Hata, T., Miller, J., Audish, D., Kotol, P., Two, A., . . . Del Rosso, J. Q. (2013). Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel. Journal of the American Academy of Dermatology, 69(4), 570-577. doi:10.1016/j.jaad.2013.05.019

Del Rosso, J. Q. (2013). Application of protease technology in dermatology: Rationale for incorporation into skin care with initial observations on formulations designed for skin cleansing, maintenance of hydration, and restoration of the epidermal permeability barrier. Journal of Clinical and Aesthetic Dermatology, 6(6), 14-22. PMCID: PMC3718746

Del Rosso, J. Q. (2013). Clinical relevance of skin barrier changes associated with the use of oral isotretinoin: The importance of barrier repair therapy in patient management. Journal of Drugs in Dermatology, 12(6), 626-631. This material can be found here.

Del Rosso, J. Q. (2013). Management of facial erythema of rosacea: What is the role of topical α-adrenergic receptor agonist therapy? [Supplemental material]. Journal of the American Academy of Dermatology, 69(6), S44-S56. doi:10.1016/j.jaad.2013.06.009

Del Rosso, J. Q. (2013). The role of skin care as an integral component in the management of acne vulgaris: Part 1: The importance of cleanser and moisturizer ingredients, design, and product selection. Journal of Clinical and Aesthetic Dermatology, 6(12), 19-27. PMCID: PMC3997205

Del Rosso, J. Q., & Brandt, S. (2013). The role of skin care as an integral component in the management of acne vulgaris: Part 2: Tolerability and performance of a designated skin care regimen using a foam wash and moisturizer SPF 30 in patients with acne vulgaris undergoing active treatment. Journal of Clinical and Aesthetic Dermatology, 6(12), 28-36. PMCID: PMC3997206

Del Rosso, J. Q., & Cash, K. (2013). Topical corticosteroid application and the structural and functional integrity of the epidermal barrier. Journal of Clinical and Aesthetic Dermatology, 6(11), 20-27. PMCID: PMC3848648

Del Rosso, J. Q., & Kircik, L. H. (2013). The integration of physiologically-targeted skin care in the management of atopic dermatitis: Focus on the use of a cleanser and moisturizer system incorporating a ceramide precursor, filaggrin degradation products, and specific "skin-barrier-friendly" excipients [Supplemental material]. Journal of Drugs in Dermatology, 12(7), s85-s91. This material can be found here.

Del Rosso, J.Q., & Kircik, L. H. (2013). The role of a midpotency topical corticosteroid and the clinical relevance of formulation characteristics in the management of commonly encountered eczematous and inflammatory dermatoses in adults and children: Focus on the pharmacologic properties of clocortolone pivalate 0.1% cream. Journal of Drugs in Dermatology, 12(2), s5-s10.